Nanovesicles containing MMP-9-sensitive lipopeptide and PEG groups released gemcitabine upon MMP-9- and glutathione-mediated hydrolysis, inhibiting pancreatic ductal carcinoma growth [141]. Here, MMP9 is linked to pancreatic ductal adenocarcinoma.